Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs Essex Property Trust, Inc. (ESS) Price & Performance

Biogen IncTrade
Essex Property Trust, Inc.Trade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Essex Property Trust, Inc. — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: Biogen Inc is the larger of the two by market cap, and Essex Property Trust, Inc. pays a 3.93% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBESS
Market Cap
$30.13B$18.15B
Sector
HealthReal Estate
52-Week High
$216.63$298.33
52-Week Low
$128.93$239.61
Enterprise Value
$37.20B$24.75B
Dividend Yield
3.93%

Returns comparison

Trailing returns across standard periods

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About Essex Property Trust, Inc.

Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.

Read more on ESS